ACS expands lung cancer screening eligibility to ages 50-80 with 20+ pack-years

Previous guideline was 55-74 with 30+ pack years

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Lung Cancer Awareness Month kicked off this week, and this is a monumental one for us at the American Cancer Society.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Robert A. Smith, PhD
Senior vice president, Early Cancer Detection Science, American Cancer Society
William L. Dahut, MD
Chief scientific officer, American Cancer Society
Table of Contents

YOU MAY BE INTERESTED IN

Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute said results of a phase II, multi-center clinical trial revealed that a new type of cell therapy is a promising potential treatment option for patients with stage 4 lung cancer who were previously treated but later developed resistance to other therapies.
Robert A. Smith, PhD
Senior vice president, Early Cancer Detection Science, American Cancer Society
William L. Dahut, MD
Chief scientific officer, American Cancer Society

Login